Standout Papers
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) (2014)
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease (2011)
Immediate Impact
36 by Nobel laureates 9 from Science/Nature 112 standout
Citing Papers
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Breast cancer
2021 Standout
Works of Baljit Singh being referenced
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
2014 Standout
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Baljit Singh | 1390 | 895 | 1027 | 948 | 46 | 3.9k | |
| Gloria H. Su | 2357 | 821 | 1295 | 896 | 91 | 5.8k | |
| Göran Hallmans | 1437 | 802 | 857 | 611 | 74 | 6.7k | |
| Elizabeth M. Ward | 1933 | 925 | 1300 | 350 | 41 | 5.9k | |
| Paige M. Bracci | 1656 | 636 | 742 | 423 | 128 | 4.2k | |
| J F Fraumeni | 1623 | 2819 | 718 | 1025 | 48 | 6.9k | |
| Arne Bakka | 1574 | 808 | 166 | 666 | 80 | 3.7k | |
| Sara H. Olson | 2413 | 564 | 504 | 1507 | 79 | 4.5k | |
| Shih-Jen Hwang | 1030 | 528 | 458 | 498 | 27 | 4.2k | |
| Irene Visintin | 927 | 824 | 850 | 3125 | 43 | 6.3k | |
| Per Lenner | 2459 | 531 | 1357 | 504 | 149 | 6.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...